• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

1-(4,5-Dibromo-2-thienyl)-1-ethanone: A Comprehensive Overview

1-(4,5-Dibromo-2-thienyl)-1-ethanone (CAS No. 7209-12-3) is a significant compound in the field of organic chemistry and pharmaceutical research. This compound, also known as ethyl 4,5-dibromo-2-thiophenecarboxylate, has garnered attention due to its unique structural properties and potential applications in various scientific domains. In this comprehensive overview, we will delve into the chemical structure, synthesis methods, biological activities, and recent research advancements of 1-(4,5-Dibromo-2-thienyl)-1-ethanone.

The chemical structure of 1-(4,5-Dibromo-2-thienyl)-1-ethanone is characterized by a thiophene ring substituted with two bromine atoms at the 4 and 5 positions and an ethanone group attached to the 2-position. The presence of these functional groups imparts distinct physical and chemical properties to the compound. The thiophene ring is a common motif in many biologically active molecules due to its aromaticity and electron-donating nature. The bromine substituents enhance the lipophilicity of the molecule, which can influence its biological activity and pharmacokinetic properties.

Synthesis of 1-(4,5-Dibromo-2-thienyl)-1-ethanone can be achieved through various methods. One common approach involves the reaction of 4,5-dibromothiophene with an appropriate acylating agent such as acetyl chloride or acetic anhydride in the presence of a base like pyridine or triethylamine. Another method involves the coupling of 4,5-dibromothiophene with an acetylene derivative followed by hydrolysis to form the desired ketone. These synthetic routes have been optimized to improve yield and purity, making 1-(4,5-Dibromo-2-thienyl)-1-ethanone readily accessible for further studies.

In terms of biological activities, 1-(4,5-Dibromo-2-thienyl)-1-ethanone has shown promise in several areas. Recent research has focused on its potential as an inhibitor of specific enzymes involved in various disease pathways. For instance, studies have demonstrated that this compound can inhibit the activity of certain kinases, which are key regulators of cellular signaling pathways implicated in cancer and inflammatory diseases. The selective inhibition of these kinases by 1-(4,5-Dibromo-2-thienyl)-1-ethanone suggests its potential as a lead compound for drug development.

Beyond enzyme inhibition, 1-(4,5-Dibromo-2-thienyl)-1-ethanone has also been investigated for its anti-inflammatory properties. In vitro studies have shown that it can reduce the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in immune cells. This effect is attributed to its ability to modulate signaling pathways involved in inflammation, making it a potential candidate for treating inflammatory disorders.

The pharmacokinetic properties of 1-(4,5-Dibromo-2-thienyl)-1-ethanone have also been studied to assess its suitability as a therapeutic agent. Research has shown that it exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. The lipophilic nature of the compound enhances its cell membrane permeability, allowing it to reach target tissues effectively. Additionally, studies have demonstrated that it is metabolically stable and does not undergo extensive first-pass metabolism.

To further validate its therapeutic potential, clinical trials are being conducted to evaluate the safety and efficacy of 1-(4,5-Dibromo-2-thienyl)-1-ethanone. Early-phase clinical trials have shown promising results in terms of safety and tolerability. However, more extensive trials are needed to fully assess its efficacy in treating specific diseases.

In conclusion, 1-(4,5-Dibromo-2-thienyl)-1-ethanone (CAS No. 7209-12-3) is a versatile compound with significant potential in pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for drug development. Ongoing research continues to uncover new applications and optimize its properties for therapeutic use. As our understanding of this compound deepens, it is likely to play an increasingly important role in advancing medical treatments for various diseases.

• 21175-51-9(2-(5-bromothiophen-2-yl)-2-oxoacetaldehyde hydrate)
• 7209-11-2(1-(4-Bromo-2-thienyl)-1-ethanone)
• 62673-72-7(Ethanone, 2-chloro-1-(3,4,5-tribromo-2-thienyl)-)
• 62673-69-2(Ethanone, 2-chloro-1-(4,5-dibromo-2-thienyl)-)
• 80775-50-4(1-PROPANONE, 3-CHLORO-1-(4,5-DIBROMO-2-THIENYL)-)
• 63723-00-2(Ethanone, 2-bromo-1-(4,5-dibromo-2-thienyl)-)
• 5370-25-2(1-(5-bromothiophen-2-yl)ethan-1-one)
• 38071-22-6(4,5-dibromothiophene-2-carbaldehyde)
• 80775-44-6(2-acetyl-3,4,5-tribromothiophene)
• 80775-52-6(1-(3,5-Dibromothiophen-2-yl)ethan-1-one)